Rapamycin Plus Bevacizumab in Advanced Cancers

NCT00667485 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: Rapamycin (liquid)
DRUG: Bevacizumab
DRUG: Rapamycin (Tablets)

Sponsor

University of Chicago

Collaborators

[object Object]